Consistently, cell profiling of BCG hydrogel-treated primary tumor showed increased frequencies of CD45+ immune cells, CD8+ and CD4+ T cells, NKT cells and NK cells, as well as iNOS+ M1 MΦ (online supplemental figure S7A–G). This evidence concerns the gene CD4 and neoplasm.